Last checked at 15 Apr 2021 17:04
GlaxoSmithKline says EMA to review VIR-7831 Covid-19 antibody
GlaxoSmithKline says EMA to review VIR-7831 Covid-19 antibody
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades3,947
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,643.00
Bid:
1,643.50
Ask:
1,644.50
Change:
3.50 (0.21%)
Spread:
1.00 (0.061%)
Open:
1,650.50
High:
1,656.00
Low:
1,637.00
Prev. Close:
1,639.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.15 Apr 2021 16:56
LONDON MARKET CLOSE: Strong US data, Wall Street earnings lift stocks
LONDON MARKET CLOSE: Strong US data, Wall Street earnings lift stocks
Read more15 Apr 2021 14:37
UPDATE 2-CureVac's COVID-19 vaccine attracts rising interest
* Says more requests have come in over past few days* CEO says having "hot" discussions with governments, COVAX* To start testing on children as young as 12 this month* Side effect scare over J&J, Astra shots clouds vaccine rollout (Adds CEO quote)...
Read more15 Apr 2021 14:37
UPDATE 1-CureVac's COVID-19 vaccine attracts rising interest
* Says more requests have come in over past few days* Says to start testing on children as young as 12 this month* Side effect scare over J&J, Astra shots clouds vaccine rollout (Adds details on children, supply contract, output goal)By Ludwig Bur...
Read more15 Apr 2021 13:59
UPDATE 2-EMA starts review of GSK's monoclonal antibody to treat COVID-19 patients
(Adds GSK-Vir statement)April 15 (Reuters) - The European Medicines Agency said on Thursday it is reviewing available data on the use of GlaxoSmithKline's monoclonal antibody to treat COVID-19 patients.The agency said its review of VIR-7831, whic...
Read more15 Apr 2021 13:59
UPDATE 1-EMA starts review of GSK's monoclonal antibody to treat COVID-19 patients
(Adds details of GSK-VIR deal, U.S. application, background on monoclonal antibodies)April 15 (Reuters) - The European Medicines Agency said on Thursday it is reviewing available data on the use of GlaxoSmithKline's monoclonal antibody to treat C...
Read more15 Apr 2021 13:26
EMA starts review of GSK's monoclonal antibody to treat COVID-19 patients
April 15 (Reuters) - The European Medicines Agency said on Thursday it is reviewing available data on the use of GlaxoSmithKline's monoclonal antibody to treat COVID-19 patients.The agency said its review of VIR-7831 will include data from a stu...
Read more15 Apr 2021 13:21
CureVac says interest in its COVID-19 vaccine on the rise
FRANKFURT, April 15 (Reuters) - German biotech firm CureVac said it had seen the number of requests for its experimental COVID-19 vaccine increase over the past few days, following a halt of the use of Johnson & Johnson's shot amid concerns over ...
Read more15 Apr 2021 13:12
UPDATE 1-Activist investor Elliott takes multibillion pound stake in GSK, FT says
(Adds context, detail)LONDON, April 15 (Reuters) - Activist hedge fund Elliott Management has taken a multi-billion pound stake in GlaxoSmithKline, the Financial Times reported on Thursday, after a year that has seen the British pharma firm take ...
Read more15 Apr 2021 12:59
PRESS: Activist investor Elliot takes stake in GlaxoSmithKline - FT
PRESS: Activist investor Elliot takes stake in GlaxoSmithKline - FT
Read more15 Apr 2021 12:47
Elliott takes multibillion pound stake in GSK, FT says
LONDON, April 15 (Reuters) - Activist hedge fund Elliott Management has taken a multi-billion pound stake in British pharmaceutical firm GlaxoSmithKline, the Financial Times reported on Thursday.Shares in GSK rose more than 7% on the report. A GSK...
Read more15 Apr 2021 12:33
Glaxo shares rally as Elliott said to have built 'significant' stake
(Sharecast News) - GlaxoSmithKline shares shot higher on Thursday as it emerged that activist hedge fund Elliott Management has built a multibillion-pound stake in the pharmaceuticals company.
Read more15 Apr 2021 12:30
CureVac says to test COVID-19 vaccine on 12-17 year-olds
FRANKFURT, April 15 (Reuters) - German biotech firm CureVac said it would start testing its COVID-19 vaccine on adolescents as young as 12 at the end of the month, as it gets ready to publish initial efficacy results for adults in the second quar...
Read more15 Apr 2021 10:58
GlaxoSmithKline and Merck discontinue trials involving feladilimab
GlaxoSmithKline and Merck discontinue trials involving feladilimab
Read more8 Apr 2021 06:53
UPDATE 2-UK-made AstraZeneca vaccines quietly sent to Australia -Sydney Morning Herald
(Adds Australian PM spokesman, UK health secretary comments)LONDON, April 8 (Reuters) - Hundreds of thousands of doses of the AstraZeneca vaccine have been flown to Australia from Britain but the source of the shipments was kept quiet to avoid any...
Read more